These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 21732293

  • 21. Preventing osteoporosis-related fractures: an overview.
    Gass M, Dawson-Hughes B.
    Am J Med; 2006 Apr; 119(4 Suppl 1):S3-S11. PubMed ID: 16563939
    [Abstract] [Full Text] [Related]

  • 22. Safety concerns with the long-term management of osteoporosis.
    Reginster JY, Pelousse F, Bruyère O.
    Expert Opin Drug Saf; 2013 Jul; 12(4):507-22. PubMed ID: 23614635
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Postmenopausal osteoporosis: fracture risk and prevention.
    Kaunitz AM, McClung MR, Feldman RG, Wysocki S.
    J Fam Pract; 2009 Nov; 58(11 Suppl Postmenopausal):S1-6. PubMed ID: 19891943
    [Abstract] [Full Text] [Related]

  • 27. Denosumab, osteoporosis, and prevention of fractures.
    Kiechl S, Willeit J, Schett G.
    N Engl J Med; 2009 Nov 26; 361(22):2188-9; author reply 2190-1. PubMed ID: 19940304
    [No Abstract] [Full Text] [Related]

  • 28. Individualizing osteoporosis medications.
    Silverman S.
    Menopause; 2014 Mar 26; 21(3):306-8. PubMed ID: 24518155
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Treatment and prevention of osteoporosis.
    Blahos J.
    Wien Med Wochenschr; 2007 Mar 26; 157(23-24):589-92. PubMed ID: 18204959
    [Abstract] [Full Text] [Related]

  • 31. [Osteoporosis priority: Reduce the number of fractures].
    Roux C.
    Presse Med; 2006 Oct 26; 35(10 Pt 2):1527-8. PubMed ID: 17028516
    [No Abstract] [Full Text] [Related]

  • 32. Individualizing osteoporosis therapy.
    Silverman S, Christiansen C.
    Osteoporos Int; 2012 Mar 26; 23(3):797-809. PubMed ID: 22218417
    [Abstract] [Full Text] [Related]

  • 33. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.
    Gallacher SJ, Dixon T.
    Calcif Tissue Int; 2010 Dec 26; 87(6):469-84. PubMed ID: 20872215
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Osteoporosis: basics and pitfalls].
    Rafeiner P.
    Praxis (Bern 1994); 2007 Jan 24; 96(4):101-6. PubMed ID: 17294585
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures.
    Cesareo R, Iozzino M, Alva D, Napolitano C, De Rosa B, Contini S, Mallardo L, Lauria A, Reda G, Orsini A.
    Minerva Endocrinol; 2007 Dec 24; 32(4):275-95. PubMed ID: 18091664
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Osteoporosis treatment in postmenopausal women with pre-existing fracture.
    Cheng MH, Chen JF, Fuh JL, Lee WL, Wang PH.
    Taiwan J Obstet Gynecol; 2012 Jun 24; 51(2):153-66. PubMed ID: 22795089
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.